AM
Insider selling
Adam M Veness sold $2.2M of Dianthus Therapeutics, Inc. /DE/ (DNTH) stock
Adam M Veness, SVP, General Counsel and Sec. of Dianthus Therapeutics, Inc. /DE/ (DNTH), sold 20,000 shares of DNTH stock worth $2.2M, per an SEC Form 4 filed Aug 11, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Aug 7, 2026, 4 days before it was made public.
DNTH has moved -11.4% since the trade date, from $108.92 to $96.47 (Sep 21, 2026 close).
- Traded
- Aug 7, 2026
- Disclosed
- Aug 11, 2026
- Filing delay
- 4 days
- Price since
- -11.4%
- Role
- SVP, General Counsel and Sec.
- Source
- SEC Form 4
More DNTH insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.